UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Apple Restores Telegram to App Store After Content Policy Violation 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
CHICAGO, March 20, 2018 -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has received approval for its common shares to trade on the Nasdaq Global Market effective at market open on March 21, 2018.
R1 shares previously traded on the Nasdaq Capital Market. Requirements for the Nasdaq Global Market are more stringent than those for the Nasdaq Capital Market. Companies must satisfy certain financial, liquidity and corporate governance requirements to be approved for listing on the Nasdaq Global Market. The Company’s ticker, “RCM,” will remain unchanged.
“The transfer of our listing to the Nasdaq Global Market reflects the financial progress R1 has made over the past year,” said Joe Flanagan, president and CEO of R1. “We are pleased to be listed on the Nasdaq Global Market, which includes some of the world's most innovative companies.”
About R1 RCM
R1 is a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care. R1’s proven and scalable operating model, the R1 Performance Stack℠, seamlessly complements a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more visit: R1RCM.com
Contact:
R1 RCM Inc.
Investor Relations:
Atif Rahim
312-324-5476
Media Relations:
Natalie Joslin
678-585-1206
